GAY, Francesca Maria

GAY, Francesca Maria  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 154 (tempo di esecuzione: 0.016 secondi).
Titolo Data di pubblicazione Autore(i) File
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 2016 Zamagni E.; Nanni C.; Gay F.; Pezzi A.; Patriarca F.; Bello M.; Rambaldi I.; Tacchetti P.; Hillengass J.; Gamberi B.; Pantani L.; Magarotto V.; Versari A.; Offidani M.; Zannetti B.; Carobolante F.; Balma M.; Musto P.; Rensi M.; Mancuso K.; Dimitrakopoulou-Strauss A.; Chauvie S.; Rocchi S.; Fard N.; Marzocchi G.; Storto G.; Ghedini P.; Palumbo A.; Fanti S.; Cavo M.
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma 2021 Holstein, Sarah A; Bahlis, Nizar; Bergsagel, P Leif; Bhutani, Manisha; Bolli, Niccolo; Brownstein, Carrie; Demolis, Pierre; Foureau, David; Gay, Francesca; Ghobrial, Irene M; Gormley, Nicole; Hillengass, Jens; Kaiser, Martin; Maus, Marcela V; Melenhorst, J Joseph; Merz, Maximilian; Dwyer, Michael O; Paiva, Bruno; Pasquini, Marcelo C; Shah, Nina; Wong, Sandy W; Usmani, Saad Z; McCarthy, Philip L
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde 2021 Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San
A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients 2012 Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini
A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients 2010 Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M
A new combination for advanced multiple myeloma. 2011 Palumbo A; Gay F.
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. 2007 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS 2010 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? 2020 D'Agostino M.; Mina R.; Gay F.
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates 2008 Montefusco V; Gay F; Spina F; Miceli R; Maniezzo M; Teresa Ambrosini M; Farina L; Piva S; Palumbo A; Boccadoro M; Corradini P.
Antibody-drug conjugates: when chemotherapy meets immuno-oncology 2021 Mina R.; Gay F.
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 2020 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Autologous transplant for myeloma: When the old meets the new 2017 Gay, Francesca*; Genuardi, Mariella; Boccadoro, Mario
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis 2017 Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M.
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma 2014 Antonio Palumbo;Federica Cavallo;Francesca Gay;Francesco Di Raimondo;Dina Ben Yehuda;Maria Teresa Petrucci;Sara Pezzatti;Tommaso Caravita;Chiara Cerrato;Elena Ribakovsky;Mariella Genuardi;Anna Cafro;Magda Marcatti;Lucio Catalano;Massimo Offidani;Angelo Michele Carella;Elena Zamagni;Francesca Patriarca;Pellegrino Musto;Andrea Evangelista;Giovannino Ciccone;Paola Omed?;Claudia Crippa;Paolo Corradini;Arnon Nagler;Mario Boccadoro;Michele Cavo
Autologous Transplantation in Elderly Multiple Myeloma Patients: Is the Procedure Cost Effective? 2015 Gay, Francesca; Palumbo, Antonio
Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients 2010 Palumbo A; Gay F; Falco P; Crippa C; Montefusco V; Patriarca F; Rossini F; Caltagirone S; Benevolo G; Pescosta N; Guglielmelli T; Bringhen S; Offidani M; Giuliani N; Petrucci MT; Musto P; Liberati AM; Rossi G; Corradini P; Boccadoro M.
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results 2013 Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A.
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma 2008 Palumbo A; Gay F; Bringhen S; Falcone A; Pescosta N; Callea V; Caravita T; Morabito F; Magarotto V; Ruggeri M; Avonto I; Musto P; Cascavilla N; Bruno B; Boccadoro M
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? 2021 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.